Company intelligence / Profile preview
Sinopharm Holding
Beijing, Beijing, Chinaen.sinopharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Sinopharm is a leading pharmaceutical and healthcare conglomerate in China, best known globally for developing and distributing the BBIBP-CorV (Sinopharm BIBP COVID-19 vaccine), which showed 78.1% efficacy against symptomatic COVID-19 and 100% efficacy against severe cases in Phase 3 trials. The company has a broad and diversified portfolio spanning vaccines, blood products, small molecules, and medical devices, with commercialized products distributed worldwide. Its COVID-19 vaccine has received WHO emergency use authorization and is widely used internationally.
- Therapeutic areas
- Infectious DiseasesNeurology
- Modalities
- VaccineBiologicSmall moleculeTraditional Chinese medicineBlood productMonoclonal antibody
- Industry
- Pharma
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Pfizer (drug approvals in China)Fresenius Kabi (Suzhou Capsugel JV)Lonza (Capsugel JV)
Beyond the preview
Go deeper on Sinopharm Holding.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sinopharm Holding.